journal article·2024-03

A Single NIR‐II Laser‐Triggered Self‐Enhancing Photo/Enzyme‐coupled Three‐in‐One Nanosystems for Breast Cancer Phototheranostics

Rong Dai, Qi Liu, Binyue Zhang, Xin Zhang, Mengting Gao, Dongsheng Li, Weiwei Kang, Lin Chen, Mingxin Zhao, Ziliang Zheng, Ruiping Zhang

Advanced Healthcare Materials· Volume 13· Issue 8
Publisher page

Abstract

Abstract Multifunctional phototheranostics, employing precise and non‐invasive techniques, is widely developed to enhance theranostic efficiency of breast cancer (BC), reduce side‐effects, and improve quality of life. Integrating all phototheranostic modalities into a single photosensitizer for highly effective BC treatment is particularly challenging due to the potential inefficiency and time consumption associated with repeated switching of multiple‐wavelength lasers. Herein, a novel single NIR‐II laser‐triggered three‐in‐one nanosystem(PdCu NY) is rationally designed, which enables dual‐modal (NIR‐II FL/NIR‐II PA) imaging‐guided self‐enhancing photothermal‐photodynamic therapy (PTT‐PDT) in NIR‐II window. The PdCu NY based on optimal Pd/Cu molar‐ratio(1:11) can be easily fabricated and large‐scale production for simultaneous PTT‐PDT against BC under a single 1064nm laser irradiation. Significantly, the PdCu NY acted as a promising photocatalyst for decomposition of H2O into O2 upon the same laser irradiation. In addition, the inherent catalase (CAT)‐like activity of PdCu NYs enables photo‐enzyme dual‐catalytic O2 supply to effectively alleviate hypoxia, achieving self‐enhanced PDT efficiency. These PTT‐PDT self‐enhanced nanosystems demonstrate precise lesion localization and complete tumor ablation using a single 1064nm laser source by “one‐laser, multi‐functions” strategy. More importantly, this study not only reports a three‐in‐one PdCu‐based phototheranostic agent, but also sheds light on the exploration of versatile biosafety nanosystems for clinical applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiology First hospital of Shanxi Medical University Taiyuan 030001 China

Institute of Medical Technology Shanxi Medical University Taiyuan 030001 China

Department of Radiology Shanxi cardiovascular hospital Taiyuan 030000 China

Funding

National Natural Science Foundation of China · China Postdoctoral Science Foundation · Shanxi Province Science Foundation for Youths · National Ten Thousand Talent Program

References (36)

Show source-provided references
1. 10.1097/RLU.000000000000367810.1097/RLU.0000000000003678 ↗
2. 10.1002/adma.20220822910.1002/adma.202208229 ↗
3. 10.1002/advs.20220471810.1002/advs.202204718 ↗
4. 10.1002/anie.20230398210.1002/anie.202303982 ↗
5. 10.1002/adhm.20220096210.1002/adhm.202200962 ↗
6. 10.1002/anie.20200589910.1002/anie.202005899 ↗
7. 10.1002/smll.20220203510.1002/smll.202202035 ↗
8. 10.1016/j.pacs.2019.10014410.1016/j.pacs.2019.100144 ↗
9. 10.1002/adfm.20190148010.1002/adfm.201901480 ↗
10. 10.1039/D0NR02543G10.1039/D0NR02543G ↗
11. 10.1002/smll.20210325210.1002/smll.202103252 ↗
12. 10.1002/smll.20220117910.1002/smll.202201179 ↗
13. 10.1016/j.mtbio.2022.10047810.1016/j.mtbio.2022.100478 ↗
14. 10.1002/adma.20210814610.1002/adma.202108146 ↗
15. 10.1021/acsnano.0c0641510.1021/acsnano.0c06415 ↗
16. 10.1007/s12274-021-3552-310.1007/s12274-021-3552-3 ↗
17. 10.1016/j.jallcom.2023.16920610.1016/j.jallcom.2023.169206 ↗
18. 10.1016/j.biomaterials.2020.12031510.1016/j.biomaterials.2020.120315 ↗
19. 10.1002/smll.20220564710.1002/smll.202205647 ↗
20. 10.1016/j.actbio.2021.10.03210.1016/j.actbio.2021.10.032 ↗
21. 10.1016/j.biomaterials.2019.11956910.1016/j.biomaterials.2019.119569 ↗
22. 10.1021/acsami.1c2175210.1021/acsami.1c21752 ↗
23. 10.1002/anie.20190675810.1002/anie.201906758 ↗
24. 10.1016/j.nantod.2020.10096010.1016/j.nantod.2020.100960 ↗
25. 10.1016/j.nantod.2020.10091910.1016/j.nantod.2020.100919 ↗
26. 10.1002/smll.20170331410.1002/smll.201703314 ↗
27. 10.1016/j.jcat.2018.02.02810.1016/j.jcat.2018.02.028 ↗
28. 10.1039/D0NR09164B10.1039/D0NR09164B ↗
29. 10.1002/anie.20230161710.1002/anie.202301617 ↗
30. 10.1038/ncomms1043710.1038/ncomms10437 ↗
31. 10.1002/anie.20210192410.1002/anie.202101924 ↗
32. 10.1021/jacs.5b1034610.1021/jacs.5b10346 ↗
33. 10.1021/jacs.2c0996710.1021/jacs.2c09967 ↗
34. 10.1021/acsnano.9b0616810.1021/acsnano.9b06168 ↗
35. 10.1016/j.matt.2021.05.02210.1016/j.matt.2021.05.022 ↗
36. 10.1021/acsnano.2c1269810.1021/acsnano.2c12698 ↗